Calliditas Therapeutics AB (publ)
Calliditas Therapeutics AB (publ) (CALT) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CALT · as of Sep 30, 2024
Ownership Breakdown
4
Institutional Holders
▼ 17 vs Q2
$750,068
Total Inst. Value
▼ $31.52M vs Q2
26.84M
Shares Outstanding
freeFloat 2.50%
18,477
13F Shares Held
▼ 806,844 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CALT largest shareholders · institutional ownership
Q3 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
CROSSMARK GLOBAL HOLDINGS, INC. pharmaceutical preparations | 16.1K | 3.00% | 3.00% | $655.00M | Nov 4, 2024 | NEW |
ADVISORS PREFERRED, LLC pharmaceutical preparations | 2.0K | 0.38% | 0.38% | $81.51M | Oct 15, 2024 | NEW |
RHUMBLINE ADVISERS pharmaceutical preparations | 303 | 0.06% | 0.06% | $12.15M | Nov 12, 2024 | ▲ 101 |
MISSOURI TRUST & INVESTMENT CO pharmaceutical preparations | 35 | 0.01% | 0.01% | $1.40M | Nov 5, 2024 | — held |
IRONWOOD INVESTMENT MANAGEMENT LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 14, 2024 | EXIT |
CIBC PRIVATE WEALTH GROUP, LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 13, 2024 | EXIT |
MORGAN STANLEY pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 14, 2025 | EXIT |
SUSQUEHANNA INTERNATIONAL GROUP, LLP pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 14, 2024 | EXIT |
CITADEL ADVISORS LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 14, 2024 | EXIT |
BVF INC/IL pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 14, 2024 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2024 vs prior quarter
Q3 2024
1
Increased
+101 shares2
New Positions
first time holders0
Decreased
−0 shares17
Sold Out
fully exitedNet shares change (top 50)
+101
+101 / −0
Net new holders
-14
2 new / 17 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CALT insider trading · insider activity
Source: SEC Form 4
Recent Insider Transactions
Showing 10 most recent · Common Stock only
No recent insider transactions reported.
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Calliditas Therapeutics AB (publ) (CALT) is primarily owned by institutional investors, who hold approximately 0.1% of total shares outstanding. Company insiders own approximately 97.50%, while retail and public investors account for the remaining 2.44%.
The largest institutional shareholder of Calliditas Therapeutics AB (publ) is CROSSMARK GLOBAL HOLDINGS, INC., holding approximately 16,117 shares — equal to 3.00% of outstanding shares — as of September 30, 2024.
A total of 4 institutional investors currently hold CALT stock, with a combined institutional value of approximately $750,068 as of the most recent 13F filing period.
Frequently asked questions
CALT ownershipCalliditas Therapeutics AB (publ) (CALT) is primarily owned by institutional investors, who hold approximately 0.1% of shares. The largest shareholder is CROSSMARK GLOBAL HOLDINGS, INC. with a 3.00% stake. Company insiders hold 97.50%. Data sourced from SEC Form 13F as of September 30, 2024.